126 related articles for article (PubMed ID: 38097094)
1. Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer.
Xin W; Tu S; Yi S; Xiong Y; Fang K; Sun G; Xiao W
Gene; 2024 Mar; 897():148078. PubMed ID: 38097094
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
Park JW; Baek IH; Kim YT
Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
[TBL] [Abstract][Full Text] [Related]
4. Promoter Hypermethylation of Tumor-Suppressor Genes
Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
[TBL] [Abstract][Full Text] [Related]
5. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Fukushima N; Sato N; Ueki T; Rosty C; Walter KM; Wilentz RE; Yeo CJ; Hruban RH; Goggins M
Am J Pathol; 2002 May; 160(5):1573-81. PubMed ID: 12000709
[TBL] [Abstract][Full Text] [Related]
7. Circulating free DNA integrity index and promoter methylation of tumor suppressor gene P16, DAPK and RASSF1A as a biomarker for oropharyngeal squamous cell carcinoma.
Kumari S; Mishra S; Anand N; Hadi R; Rastogi M; Husain N
Pathol Res Pract; 2023 Jun; 246():154489. PubMed ID: 37150134
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of neuronal pentraxin II methylation in patients with pancreatic cancer: Meta-analysis.
Huang W; Xue L; Xu H; Kong Z; Xu J; Zhao H; Nie Y
Int J Clin Pract; 2021 Sep; 75(9):e14443. PubMed ID: 34105851
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864
[TBL] [Abstract][Full Text] [Related]
10. Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.
García-Ortiz MV; Cano-Ramírez P; Toledano-Fonseca M; Cano MT; Inga-Saavedra E; Rodríguez-Alonso RM; Guil-Luna S; Gómez-España MA; Rodríguez-Ariza A; Aranda E
Clin Epigenetics; 2023 Jul; 15(1):118. PubMed ID: 37481552
[TBL] [Abstract][Full Text] [Related]
11. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
House MG; Herman JG; Guo MZ; Hooker CM; Schulick RD; Lillemoe KD; Cameron JL; Hruban RH; Maitra A; Yeo CJ
Ann Surg; 2003 Sep; 238(3):423-31; discussion 431-2. PubMed ID: 14501508
[TBL] [Abstract][Full Text] [Related]
12. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma.
Ohtsubo K; Watanabe H; Yao F; Okada G; Mouri H; Yamaguchi Y; Sawabu N
J Gastroenterol; 2006 Aug; 41(8):791-7. PubMed ID: 16988769
[TBL] [Abstract][Full Text] [Related]
13. Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms.
Chhoda A; Sharma A; Sailo B; Tang H; Ruzgar N; Tan WY; Ying L; Khatri R; Narayanan A; Mane S; De Kumar B; Wood LD; Iacobuzio-Donahue C; Wolfgang CL; Kunstman JW; Salem RR; Farrell JJ; Ahuja N
Clin Epigenetics; 2023 Feb; 15(1):28. PubMed ID: 36803844
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.
Fukushima N; Walter KM; Uek T; Sato N; Matsubayashi H; Cameron JL; Hruban RH; Canto M; Yeo CJ; Goggins M
Cancer Biol Ther; 2003; 2(1):78-83. PubMed ID: 12673124
[TBL] [Abstract][Full Text] [Related]
16. Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.
Haldrup C; Pedersen AL; Øgaard N; Strand SH; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Mol Oncol; 2018 Apr; 12(4):545-560. PubMed ID: 29465788
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
18. Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma.
Mohammadi-asl J; Larijani B; Khorgami Z; Tavangar SM; Haghpanah V; Kheirollahi M; Mehdipour P
Med Oncol; 2011 Dec; 28(4):1123-8. PubMed ID: 20535589
[TBL] [Abstract][Full Text] [Related]
19. Methylation of Tumor Suppressor Genes in Autoimmune Pancreatitis.
Kinugawa Y; Uehara T; Sano K; Matsuda K; Maruyama Y; Kobayashi Y; Nakajima T; Hamano H; Kawa S; Higuchi K; Hosaka N; Shiozawa S; Ishigame H; Ota H
Pancreas; 2017; 46(5):614-618. PubMed ID: 28196014
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma.
Affolter KE; Hellwig S; Nix DA; Bronner MP; Thomas A; Fuertes CL; Hamil CL; Garrido-Laguna I; Scaife CL; Mulvihill SJ; Underhill HR
Neoplasia; 2021 Sep; 23(9):859-869. PubMed ID: 34298235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
